
The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus
Keywords: Dendritic cells (DCs); Hepatitis C virus (HCV) infection; Immune response; Immune therapy; Myeloid-derived suppressor cells (MDSC); Natural killer (NK) cells; Regulatory T cells; IFN-α; Ribavirin therapy; TLR